Real-WorlD ZolbetUximab in Patients With HER-2 Negative and CLaudin 18.2 PosItive MetastatiC AdEnocarcinoma

Clinical trial NCT07427992 · RECRUITING

Trial details

NCT number: NCT07427992
Sponsor: European Institute of Oncology
Status: RECRUITING
Study type: OBSERVATIONAL

Gastric Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2025-06-20
Primary completion: 2026-12-30
Enrollment: 70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.